We compared baseline characteristics (N = 102) and five-year outcomes (N = 52) in these subgroups.
We compared baseline characteristics of Hispanic participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC (H-CRIC) Studies with non-Hispanic CRIC participants.
We compared baseline characteristics and survival of patients managed with rate- versus rhythm-control strategies.
We compared baseline characteristics of 825 patients treated with amiodarone at randomization with 13,875 patients not treated with amiodarone.
We compared baseline characteristics, resource use, and inhospital mortality among 3936 Hispanics and 90280 non-Hispanic whites with NSTE ACS from the CRUSADE Quality Improvement Initiative.
We compared baseline characteristics and assessed associations between mode of administration (bolus vs continuous) and outcomes in patients receiving high-dose (≥120 mg furosemide equivalent, n = 177) versus low-dose (<120 mg furosemide equivalent, n = 131) outpatient diuretics.
We compared baseline characteristics and clinical outcome of IPAF patients with those of the population of ARDS patients admitted in the same period.
We also compared baseline characteristics and outcomes of all 983 patients enrolled in the LOV Study who received and did not receive NMBs.
Outcome measures compared baseline characteristics and clinical outcomes through 30 months by 2010 country-level United Nations Human Development Indices (HDIs) and per-capita gross national income.TRILOGY ACS enrolled 3659 patients from 27 very-high HDI countries, 3744 from 18 high-HDI countries and 1898 from 6 medium-HDI countries.
The nonrodent/nonrabbit publications more often compared baseline characteristics of treatment groups and mentioned limitation to external validity; they less often had extra animals used in the results that were not mentioned in the Methods.
After dividing patients into the three psychiatric diagnosis groups, we compared baseline characteristics, past medical history and medication prescription between the bipolar disorder, schizophrenia and schizoaffective disorder diagnostic groups.
